Brigham and Women's Hospital investigators link very high lipoprotein(a) with a higher 30-year risk of major cardiovascular ...

A nearly 30-year study shows a strong long-term association between very high lipoprotein(a) levels and cardiovascular ...

Elevated lipoprotein(a) levels can slowly block the arteries, increasing the likelihood of cardiovascular disease. Since no treatment is currently available for this condition, it is essential to ...

It is of utmost importance to maintain healthy cholesterol levels. While cholesterol is essential for various bodily functions, having too much cholesterol in your bloodstream can lead to serious ...

Fluctuating LDL and total cholesterol levels in older adults may indicate increased dementia and cognitive decline risk. Higher cholesterol variability correlates with a greater incidence of dementia ...

Deleterious effect of lipoprotein(a) ≥180 nmol/L possibly mitigated by high-impact LDL-cholesterol-lowering therapy. (HealthDay News) — Higher lipoprotein(a) levels are associated with continuously ...

A study finds that a blood test that evaluates levels of three compounds — lipoprotein(a), C-reactive protein (a marker of inflammation), and “bad” LDL cholesterol — can accurately reveal heart ...

Reduction in levels seen using an intact lipoprotein(a) assay and apolipoprotein(a)-based assay. (HealthDay News) — Muvalaplin reduces lipoprotein(a) levels, according to a study published online in ...

Eli Lilly LLY announced that its investigational oral, once-daily cholesterol-lowering drug muvalaplin reduced lipoprotein(a) or Lp(a) levels in adults with high risk of cardiovascular events in a ...